Analyst Liana Moussatos of Wedbush rates stocks in the biotechnology sector and is one of the top 100 analysts rated on TipRanks. Today, Moussatos provided commentary …
Analyst Alan Carr of Needham rates stocks in the biotechnology sector and is one of the top 25 analysts rated on TipRanks. Today, …
Cowen remains bullish on Intercept Pharmaceuticals Inc (NASDAQ:ICPT) as the company designs Phase 2 and 3 trials for its pipeline drug aimed to …
Analysts are weighing in on the Valencia biomedical company MannKind Corporation (NASDAQ:MNKD) and biopharmaceutical company Intercept Pharmaceuticals Inc (NASDAQ:ICPT), as both stocks are suffering losses on …
Needham’s healthcare analyst Alan Carr reiterated a Buy rating on shares of the liver disease company Intercept Pharmaceuticals Inc (NASDAQ:ICPT), with a price target of $500, …
Several pharmaceutical giants will be releasing earnings reports this week. Here’s what to watch for in reports from MannKind Corporation (NASDAQ:MNKD), Intercept Pharmaceuticals …
Top-ranked analyst Alan Carr weighed in on two biotech giants this week, Gilead Sciences, Inc. (NASDAQ:GILD) and Intercept Pharmaceuticals Inc.
Apple Inc. (NASDAQ:AAPL) shares are up 1.
Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic underserved liver diseases, today …
In light of upcoming events in the biotechnology sector slated for the fourth quarter of this year, Needham analyst Alan Carr weighed in …
